199 related articles for article (PubMed ID: 17674311)
61. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
Cederarv M; Söderberg-Nauclér C; Odeberg J
Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
[TBL] [Abstract][Full Text] [Related]
62. Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells.
Kim EK; Cho HI; Yoon SH; Park MJ; Sohn HJ; Kim HJ; Oh ST; Kim TG
Vaccine; 2008 Jul; 26(32):3987-97. PubMed ID: 18584926
[TBL] [Abstract][Full Text] [Related]
63. Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential.
Bewarder M; Held G; Thurner L; Stilgenbauer S; Smola S; Preuss KD; Carbon G; Bette B; Christofyllakis K; Bittenbring JT; Felbel A; Hasse A; Murawski N; Kaddu-Mulindwa D; Neumann F
Cancer Immunol Immunother; 2020 Aug; 69(8):1535-1548. PubMed ID: 32300857
[TBL] [Abstract][Full Text] [Related]
64. Clinical aspects and management of cytomegalovirus infection.
Sissons JG; Carmichael AJ
J Infect; 2002 Feb; 44(2):78-83. PubMed ID: 12076065
[TBL] [Abstract][Full Text] [Related]
65. Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.
Herr W; Plachter B
Expert Rev Vaccines; 2009 Aug; 8(8):999-1021. PubMed ID: 19627184
[TBL] [Abstract][Full Text] [Related]
66. [Mechanisms in evasion of host immune response by HCMV].
Satoh T; Arase H
Nihon Rinsho; 2006 Mar; 64 Suppl 3():421-6. PubMed ID: 16615508
[No Abstract] [Full Text] [Related]
67. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
68. A fingerprint left by cytomegalovirus infection in the human T cell compartment.
van de Berg PJ; van Stijn A; Ten Berge IJ; van Lier RA
J Clin Virol; 2008 Mar; 41(3):213-7. PubMed ID: 18061537
[TBL] [Abstract][Full Text] [Related]
69. Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients.
Garrigue I; Corte MF; Magnin N; Couzi L; Capdepont S; Rio C; Merville P; Dechanet-Merville J; Fleury H; Lafon ME
J Clin Virol; 2007 Oct; 40(2):120-8. PubMed ID: 17827058
[TBL] [Abstract][Full Text] [Related]
70. Dissection of the CMV specific T-cell response is required for optimized cardiac transplant monitoring.
Kirchner A; Hoffmeister B; Cherepnev-G G; Fuhrmann S; Streitz M; Lachmann R; Bunde T; Meij P; Schönemann C; Hetzer R; Lehmkuhl HB; Volkmer-Engert R; Volk HD; Gratama JW; Kern F
J Med Virol; 2008 Sep; 80(9):1604-14. PubMed ID: 18649330
[TBL] [Abstract][Full Text] [Related]
71. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
[TBL] [Abstract][Full Text] [Related]
72. A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.
Adler SP; Manganello AM; Lee R; McVoy MA; Nixon DE; Plotkin S; Mocarski E; Cox JH; Fast PE; Nesterenko PA; Murray SE; Hill AB; Kemble G
J Infect Dis; 2016 Nov; 214(9):1341-1348. PubMed ID: 27521362
[TBL] [Abstract][Full Text] [Related]
73. [Mannose-binding lectin (MBL) inhibits human cytomegalovirus infection of human MD-DC].
Pan KY; Shang SQ; Chen YH; Wu W; Qiao HJ; Tao R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):599-603, 615. PubMed ID: 22007480
[TBL] [Abstract][Full Text] [Related]
74. Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation.
Sundarasetty BS; Kloess S; Oberschmidt O; Naundorf S; Kuehlcke K; Daenthanasanmak A; Gerasch L; Figueiredo C; Blasczyk R; Ruggiero E; Fronza R; Schmidt M; von Kalle C; Rothe M; Ganser A; Koehl U; Stripecke R
J Transl Med; 2015 Jul; 13():240. PubMed ID: 26198406
[TBL] [Abstract][Full Text] [Related]
75. Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern?
Schleiss MR
Rev Med Virol; 2006; 16(2):73-82. PubMed ID: 16287195
[TBL] [Abstract][Full Text] [Related]
76. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.
Adler SP; Starr SE; Plotkin SA; Hempfling SH; Buis J; Manning ML; Best AM
J Infect Dis; 1995 Jan; 171(1):26-32. PubMed ID: 7798679
[TBL] [Abstract][Full Text] [Related]
77. CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection.
Kvale EØ; Dalgaard J; Lund-Johansen F; Rollag H; Farkas L; Midtvedt K; Jahnsen FL; Brinchmann JE; Olweus J
Blood; 2006 Mar; 107(5):2022-9. PubMed ID: 16269620
[TBL] [Abstract][Full Text] [Related]
78. Dendritic cells and HCMV cross-presentation.
Arrode G; Davrinche C
Curr Top Microbiol Immunol; 2003; 276():277-94. PubMed ID: 12797453
[TBL] [Abstract][Full Text] [Related]
79. Successful immunotherapy of HCMV disease using virus-specific T cells expanded from an allogeneic stem cell transplant recipient.
Hill GR; Tey SK; Beagley L; Crough T; Morton JA; Clouston AD; Whiting P; Khanna R
Am J Transplant; 2010 Jan; 10(1):173-9. PubMed ID: 19919660
[TBL] [Abstract][Full Text] [Related]
80. Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes.
Odeberg J; Wolmer N; Falci S; Westgren M; Sundtröm E; Seiger A; Söderberg-Nauclér C
J Neurosci Res; 2007 Feb; 85(3):583-93. PubMed ID: 17154414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
